Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 12 | $14,597,546 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Dec 2022 17:20 | GMED | GLOBUS MEDICAL INC | HULLER KELLY | SVP, GC, Corporate Secretary | 01 Dec 2022 | Sale | 7,500 | 75.0001 | 562,501 | D |
06 Feb 2023 16:43 | GMED | GLOBUS MEDICAL INC | PFEIL KEITH W | SVP, Chief Financial Officer | 19 Aug 2021 | Sale A | 833 | 76.13 | 63,416 | D |
06 Feb 2023 16:52 | GMED | GLOBUS MEDICAL INC | PFEIL KEITH W | SVP, Chief Financial Officer | 02 Feb 2023 | Sale | 29,167 | 77.568 | 2,262,426 | D |
17 May 2023 16:31 | GMED | GLOBUS MEDICAL INC | LEMAITRE DAN | Director | 15 May 2023 | Sale | 43,450 | 56.9845 | 2,475,977 | D |
05 Mar 2024 17:07 | GMED | GLOBUS MEDICAL INC | HULLER KELLY | SVP, GC, Corporate Secretary | 01 Mar 2024 | Sale | 3,115 | 54.53 | 169,861 | D |
05 Mar 2024 17:07 | GMED | GLOBUS MEDICAL INC | HULLER KELLY | SVP, GC, Corporate Secretary | 01 Mar 2024 | Sale | 4,385 | 53.79 | 235,869 | D |
19 Mar 2024 19:40 | GMED | GLOBUS MEDICAL INC | NORWALK LESLIE V | Director | 15 Mar 2024 | Sale | 10,590 | 51.99 | 550,574 | D |
10 May 2024 16:48 | GMED | GLOBUS MEDICAL INC | DAVIDAR DAVID D | Director | 08 May 2024 | Sale | 20,000 | 65 | 1,300,000 | D |
14 May 2024 17:16 | GMED | GLOBUS MEDICAL INC | LEMAITRE DAN | Director | 10 May 2024 | Sale | 63,300 | 64.6133 | 4,090,022 | D |
15 Jul 2024 16:25 | GMED | GLOBUS MEDICAL INC | NORWALK LESLIE V | Director | 11 Jul 2024 | Sale | 1,000 | 70 | 70,000 | D |
17 Sep 2024 16:31 | GMED | GLOBUS MEDICAL INC | DAVIDAR DAVID D | Director | 13 Sep 2024 | Sale | 25,000 | 70.46 | 1,761,500 | D |
17 Sep 2024 16:34 | GMED | GLOBUS MEDICAL INC | RHOADS ANN D | Director | 13 Sep 2024 | Sale | 15,000 | 70.36 | 1,055,400 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)